id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2012-E-1234-0007,FDA,FDA-2012-E-1234,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2015-03-10T04:00:00Z,2015,3,2015-03-10T04:00:00Z,,2015-03-10T16:42:42Z,,0,0,0900006481a389f4
FDA-2012-E-1234-0006,FDA,FDA-2012-E-1234,"Determination of Regulatory Review Period for Purposes of Patent
Extension; STENDRA",Notice,General Notice,2014-06-10T04:00:00Z,2014,6,2014-06-10T04:00:00Z,2014-08-12T03:59:59Z,2014-06-10T16:04:46Z,2014-13444,0,0,090000648173521c
FDA-2012-E-1234-0005,FDA,FDA-2012-E-1234,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2014-05-12T04:00:00Z,2014,5,2014-05-12T04:00:00Z,,2014-05-12T16:40:07Z,,0,0,09000064816f1540
FDA-2012-E-1234-0004,FDA,FDA-2012-E-1234,Letter from U.S. Patent and Trademark Office  to FDA CDER,Other,Letter(s),2014-03-28T04:00:00Z,2014,3,2014-03-28T04:00:00Z,,2014-03-28T20:00:27Z,,0,0,090000648168cf7a
FDA-2012-E-1234-0003,FDA,FDA-2012-E-1234,Letter to U. S. Patent & Trademark Office,Other,Letter(s),2013-02-14T05:00:00Z,2013,2,2013-02-14T05:00:00Z,,2024-03-15T11:04:43Z,,0,0,09000064811f89d9
FDA-2012-E-1234-0001,FDA,FDA-2012-E-1234,"Mitsubishi Tenabe Pharma Corp. (Finnegan, Henderson, Farabow, Garrett & Dunner LLP) - Patent Extension Application",Other,Application,2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:10:24Z,,0,0,090000648119d265
FDA-2012-E-1234-0002,FDA,FDA-2012-E-1234,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-12-28T05:00:00Z,2012,12,2012-12-28T05:00:00Z,,2012-12-28T13:10:25Z,,0,0,090000648119d267